The function of the p53 protein as the central effector molecule of the p53 apoptotic pathway was investigated in a reversible model of epigenetic transformation. The infection of bovine leukocytes by the intracellular protozoan parasite Theileria annulata results in parasitedependent transformation and proliferation of the host cells. We found p53 to be largely localized in the host cell cytoplasm and associated with the parasite membrane of isolated schizonts. Curing infected cells of the parasite with the theilericidal drug buparvaquone resulted in a time-dependent translocation of p53 into the host cell nucleus and the upregulation of the proapoptotic Bax and Apaf-1 and the downregulation of the anti-apoptotic Bcl-2 proteins. Although buparvaquone treatment led to apoptosis of the host cell, inhibition of either p53 or Bax significantly reduced buparvaquone-induced apoptosis of the transformed cells. Thus, the p53 apoptotic pathway of host cells is not induced by infection and transformation with Theileria by a mechanism involving cytoplasmic sequestration of p53. The close association of host cell p53 with the parasite membrane implies that the parasite either interacts directly with p53 or mediates cytoplasmic sequestration of p53 by interacting with other host cell proteins regulating p53 localization.
Introduction
In almost all instances, deregulated cell proliferation and suppression of cell death together provide the underlying platform for neoplasia. The p53 gene product is one of the most important proteins that is involved in both the regulation of proliferation and apoptosis and thus represents a key molecule in tumor formation. The normal function of the p53 protein is to arrest cell division and to initiate apoptosis in the case of cell stress and DNA damage, protecting the integrity of the genome. The central function of p53 in preventing the onset of cancer is underlined by the observation that p53 is mutated in the majority of human cancers and that tumors that lack p53 function are often refractory to radiation or chemotherapy treatment (Levine, 1997) . Besides structural mutation, the functional inactivation of p53 not only can contribute to malignancy, but also can be established by local immobilization of p53 through anchor molecules or the formation of heterodimers, as for example with the adenovirus protein E1B (Boyd et al., 1994) , the human papillomavirus protein E6 (Scheffner et al., 1990) or the SV40 T-large antigen (Lane and Crawford, 1979) .
On activation by cellular stress signals, p53 as a transcription factor transactivates a relatively large number of genes involved in cell-cycle arrest, genome stability, cellular senescence, angiogenesis and apoptosis by binding to specific DNA target sequences (Vogelstein et al., 2000) . The p53-regulated intrinsic apoptosis pathway involves the activation and regulation of proteins including members of the pro-and antiapoptotic members of the Bcl-2 family, resulting in the activation of the apoptosome, which includes cytochrome c, Apaf-1 and caspase 9 (Adams and Cory, 2002) . The apoptosome activates several downstream effector caspases that finally lead to cell destruction. Loss of function of p53 may thus result in inhibition of this p53-dependent pathway and contribute to unrestrained proliferation by supporting cell survival. Regulation of p53 function itself is tightly controlled through several mechanisms, including transcription, translation, protein stability, post-translational modification and intracellular localization (Liang and Clarke, 2001; O'Brate and Giannakakou, 2003) . The understanding of the complex effects of p53-regulated apoptotic events as well as the regulation of p53 function is believed to be central to understanding cell survival in the context of neoplasia and in devising strategies of tumor therapy.
In this study, we have investigated the p53 apoptotic pathway in a model of reversible leukoproliferative neoplasia. The schizont stage of the intracellular apicomplexan parasite Theileria annulata, which causes tropical theileriosis in cattle, shares the unique property of leukoproliferative Theileria to immortalize its leukocyte host cells such that they undergo clonal expansion and acquire characteristics of metastatic tumor cells (Ahmed et al., 1999) . Importantly, Theileria-induced transformation is reversible and parasite dependent, because specific elimination of the parasites from infected cells by the naphthoquinone derivate buparvaquone results in cessation of proliferation and apoptosis of the host cell (McHardy and Wekesa, 1985; Dobbelaere et al., 1988; Shayan et al., 1999) . It is thus postulated that the parasite interferes with mitogenic pathways of the host cell, and several pathways, including the stress-dependent c-Jun kinase pathway (Galley et al., 1997) , the mitogen-activated protein kinase pathway and the phosphoinositide-3 kinase/ protein kinase-B pathway, have been investigated (Heussler et al., 2001; Seitzer et al., 2006) . Other studies indicated a direct parasite interaction with members of the nuclear factor-kB pathway, leading to the continuous translocation of active nuclear factor-kB to the nucleus of infected cells and thus the transcription of genes related to cell-cycle progression and suppression of apoptosis (Heussler et al., 2002) . Also with respect to cell survival, Guergnon et al. (2003) found that caspase 9 and 3 become active during treatment of T. parva-infected cells, indicating that the lack of activation of caspase 9 and 3 is important and protects T. parva-transformed cells from spontaneous apoptosis. These results point toward a parasite influence on the transcription factor p53 because activation of caspase 9 is strictly dependent on the p53 apoptosis pathway.
This study investigated apoptosis-related events regulated by p53 as a possible target for parasite interaction, showing that the p53 apoptotic pathway is inhibited by the presence of the parasite, contributing to protection from spontaneous apoptosis and thus to survival of Theileria-infected cells.
Results
Subcellular localization of p53 in Theileria-infected cells Besides mutations leading to inactivation of p53, p53 function is also regulated by intracellular localization (Liang and Clarke, 2001; O'Brate and Giannakakou, 2003) . Confocal microscopy analysis indicated that in Theileria-infected cells, the major portion of p53 was located in the cytoplasm and appeared to be enriched in the vicinity of the macroschizont (Figure 1 ). To elucidate whether the presence of the parasite influences the subcellular localization of host cell p53, we cured TaA288 cells of the parasite by buparvaquone treatment and determined the subcellular localization of p53 at the indicated time points. As shown in Figure 2 , killing of Theileria schizonts led to a time-dependent translocation of p53 to the host cell nucleus. Already 3 h after buparvaquone treatment, p53 could be observed in increased amounts in the nucleus of infected cells. After 13 h of theilericidal drug treatment, cells contained the major proportion of p53 immunoreactivity in the nucleus, concurrent with an almost complete obliteration of the Theileria schizont. p53 was also found to be associated with the parasite membrane of T. parvaand T. lestoquardi-infected cells (data not shown). In contrast, uninfected bovine PBMCs and ConAstimulated PBMCs contained the major portion of p53 Figure 1 The majority of host cell p53 is localized at the schizont membrane in Theileria-infected cells. TaA288 cells were subjected to immunostaining for detection of nucleic acids (DAPI, blue signals, panels a and e), the Theileria annulata surface membrane (Alexa-488, green signals, panels b and f) and host cell p53 (Alexa-568, red signals, panels c and g). The merged images are shown in panels d and h. Detection of host cell p53 in T. annulata-infected cells revealed cytoplasmic localization of the majority of p53 in the vicinity of the parasite membrane as pointed out with the arrows. Small amounts of p53 are also observed in the nucleus of some cells. Size bars: 10 mm.
in the nucleus and showed no significant redistribution of subcellular localization of p53 after buparvaquone treatment ( Supplementary Figures 1 and 2 ).
Transcription levels of apoptosis-related genes regulated by p53
To analyze a possible correlation of p53 localization and function in TaA288 cells, we determined expression levels of the apoptosis-related and p53-transactivated genes Bax, Apaf-1 and Bcl-2 before and after buparvaquone treatment. Control incubations of ConA-stimulated bovine PBMCs with buparvaquone were analyzed in parallel. Samples taken in the time intervals indicated were analyzed using real-time PCR (Figures 3a-c) .
Relative mRNA transcription levels of the proapoptotic protein Bax increased fivefold after 2 h of treatment (0 h ¼ 0.36; 2 h ¼ 1.84), then declined to remain at a constant twofold level until the 24 h time point. The relative transcript levels of Apaf-1 were increased fivefold after 2 h, peaked sixfold after 11 h of treatment (0 h ¼ 0.516; 11 h ¼ 2.97) and remained at this level after 24 h of treatment. In contrast to the increased levels of mRNA transcripts of the proapoptotic Bax and Apaf-1 genes, the relative amounts of mRNA of the anti-apoptotic Bcl-2 mRNA declined from 1 to 24 h of treatment to approximately half of the starting amount (0 h ¼ 9.986; 24 h ¼ 5.071). Control incubations exhibited low levels of the transcripts with no apparent changes in level during the time frame investigated for any of the transcripts analyzed.
Protein expression of Bax, Apaf-1 and Bcl-2 Western blot experiments were performed on buparvaquone-treated TaA288 cells to determine whether the observations made on the transcript level of the apoptosis-related genes were reflected on the protein expression level (Figure 3d ). It could be clearly shown that protein expression of the proapoptotic proteins Bax and Apaf-1 increased from 3 h of treatment to peak levels at 24 and 12 h, respectively. In contrast, protein expression of anti-apoptotic Bcl-2 decreased continuously starting after 1 h of treatment to undetectable levels after 9 h of treatment. Western blots of ConAstimulated PBMCs with and without buparvaquone did not give any detectable signal at any of the time points investigated (data not shown).
Inhibition of the p53 apoptotic pathway
The preceding experiments indicated that the upregulation of the proapoptotic proteins Bax and Apaf-1 and the simultaneous downregulation of the anti-apoptotic protein Bcl-2 could be involved in apoptosis of parasitecured host cells during treatment with buparvaquone. To investigate the consequence on apoptosis induction by specifically inhibiting the p53 apoptotic pathway during buparvaquone treatment, we applied pifithrin-a as a potent chemical inhibitor of p53 and Bax-inhibiting peptide in incubation experiments with buparvaquoneanalyzing caspase 3 and 7 activity as parameters of apoptosis induction. The results showed that the activity of caspase 3 and 7 was significantly increased after 7, 9
Figure 2 Host cell p53 is translocated to the host cell nucleus on killing of the parasite. Buparvaquone-treated TaA288 cells were subjected to immunostaining for detection of nucleic acids (DAPI, blue signals, panels a and e), the Theileria annulata surface membrane (Alexa-488, green signals, panels b and f) and host cell p53 (Alexa-568, red signals, panels c and g). The merged images are shown in panels d and h. Host cell p53 is translocated to the host cell nucleus in a time-dependent manner during buparvaquone treatment of infected cells (a-d, 3 h; e-h, 2 h). Size bars: 10 mm.
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and 12 h of treatment in the buparvaquone-treated samples compared with the incubation with buparvaquone in addition to either one of the inhibitors (Figure 4) . The enzyme activity measured in pifithrin-a or Bax-inhibiting peptide-treated samples remained at constant low levels up to 12 h treatment. From 14 h onward, a rise in caspase activity was also observed in these cultures, most likely to be attributed to the consumption of the inhibitory agents.
Association of p53 with the Theileria macroschizont
The results to this point indicated that the presence of the parasite in the transformed cells correlates with p53 subcellular localization and function. To gain insight into a direct interaction between the parasite and the p53 host protein, we isolated and subjected macroschizonts to immunofluorescence staining for the detection of p53 immunoreactivity. The results clearly showed that the p53 antibody reacted with small globular particles found at the schizont membrane of isolated parasites (Figure 5a ). Control experiments with inhibition of p53 immunoreactivity by preincubation of the p53 antibody with recombinant bovine p53 (Figure 5b ), detection of a nuclear antigen (trimethylated Histone 3 Lysine 9, Figure 5c ), isotype controls and secondary reagents only clearly underlined the specificity of this observation. p53 was also found to be associated with isolated schizonts of T. parva-infected cells (data not shown).
Discussion
The key findings of this study are that the presence of the T. annulata schizont leads to cytoplasmic sequestration of the majority of host cell p53, resulting in the inhibition of p53-mediated apoptosis and promotion of host cell survival. Elimination of the parasite leads to nuclear translocation of p53, resulting in the upregulation of the proapoptotic proteins and the downregula- tion of an anti-apoptotic protein, the activation or deactivation of which ultimately lead to host cell apoptosis.
The translocation of p53 to the host cell nucleus as a consequence of drug treatment led to a noteworthy change in transcription and expression levels of p53 subordinated genes involved in p53-mediated apoptosis, namely, an upregulation of the proapoptotic proteins Bax and Apaf-1 and a downregulation of the antiapoptotic protein Bcl-2. This pathway to apoptosis is regulated by the interplay of the pro-and anti-apoptotic members of the Bcl-2 family. The function of the antiapoptotic Bcl-2 protein, which is negatively regulated by p53 (Wu et al., 2001) , blocks the mitochondrial release of cytochrome c and thereby prevents activation of the apoptosome. The description of a negative response element through which p53 may directly downregulate the expression of Bcl-2 provides support for the observed decrease in Bcl-2 expression to be based on enhanced p53 translocation. The proapoptotic Bax protein, which is positively regulated by p53 (Miyashita and Reed, 1995) , causes the mitochondrial release of cytochrome c (Shimizu et al., 1999) , which, together with the p53 positively regulated Apaf-1 (Fortin et al., 2001 ) and caspase 9, assembles to form the apoptosome. It has been emphasized that the level of Bax represents the crucial factor for the induction of apoptosis through p53, and that Bax and Bcl-2 were shown to be antagonistic key members for balancing cells between survival and apoptotic signaling (Shimizu et al., 1999) . The upregulation of Bax and Apaf-1 after curing cells with buparvaquone is thus a strong indication that inhibition of p53 as an inducer of apoptosis represents a key event during Theileria infection and may stabilize the parasite-controlled transformation. The physiological importance of our findings was emphasized by inhibition experiments against p53-induced apoptosis, and thus the specific Theileria-mediated inhibition of a p53-mediated host cell apoptosis was shown. However, a complete inhibition was not observed, indicating the influence or modulation of other p53-independent apoptotic pathways by the parasite, such as the modulation of nuclear factor-kB activity (Heussler et al., 2002) .
The proposed mechanism of p53 inactivation is epigenetic in nature because p53 function was restored on parasite elimination. The transformation caused by T. annulata thus exploits the regulation of p53 localization to modulate p53 function, whereby we propose this as a general mechanism in leukoproliferative Theileria, because similar findings were obtained with T. parva and T. lestoquardi. The association of p53 with the Theileria schizonts points to a potential direct or indirect interaction of p53 through other host molecules with one or more parasite proteins either expressed on the schizont surface or secreted into the host cell lumen, resulting in the immobilization of p53 in the cytoplasm and thus inhibiting its function. Activation of p53 can be modulated basically at different levels, including posttranslational modifications, transcription, translation Figure 4 Inhibition of the p53 apoptotic pathway with the specific inhibitors of p53 pifithrin-a and the Bax-inhibiting peptide (BIP) significantly delays apoptosis in buparvaquone-treated TaA288 cells. TaA288 cells were incubated with buparvaquone to kill the parasite (Bup), and two parallel incubations were performed containing in addition either the p53-inhibitor pifithrin-a (Bup/ Pif) or Bax-inhibiting peptide (Bup/BIP). Coincubating the cells with inhibitors of proteins involved in the p53 apoptotic pathway significantly inhibits apoptosis of buparvaquone-treated cells. Induction of apoptosis was analyzed using an assay that detects caspase-3/7 activity by measuring fluorescence emitted by the caspase-3/7 substrate rhodamine 110, which exists as a profluorescent substrate before the assay. Depicted are the mean values and standard deviations of the relative fluorescence units (RFU), *Po0.05, **Po0.01. Cytoplasmic sequestration of p53 D Haller et al and protein stability, and intracellular localization (Moll et al., 1996) . In untransformed cells, p53 is translated in the cytoplasm and shuttled into the cell nucleus during the late G1 phase. After passing the S-phase, the protein is back-exported to the cytoplasm. Knippschild et al. (1996) describe the high transformation potential of a cytoplasmic arrest of p53 in different cell lines as a consequence of association with 'anchor' proteins. The oncogene mdm-2 constitutes such an interacting protein, the overexpression of which established the constitutive degradation of p53 in the cytoplasm leading to its nuclear exclusion (Oliner et al., 1993) . Nikolaev et al. (2003) identified the parkin-like ubiquitin ligase (PARC) as a cytoplasmic p53-binding protein that forms complexes with p53 and thereby prevents a protein transport to the nucleus. In any case, the immobilization of p53 always leads to dysfunction of the cell-cycle control, apoptotic pathways and DNA repair systems (Oliner et al., 1993) . In fact, wild-type p53 is functionally inactivated by abnormal cytoplasmic sequestration in many tumor types, including inflammatory breast carcinoma, undifferentiated neuroblastoma, colorectal carcinoma and retinoblastoma. Constitutive cytoplasmic localization of p53 in these tumors has been linked with poor response to chemotherapy, tumor metastasis and poor long-term patient survival (Moll et al., 1992 (Moll et al., , 1995 Sun et al., 1992; Bosari et al., 1995; Ueda et al., 1995; Schlamp et al., 1997) . Elucidation of the mechanisms involved in the cytoplasmic sequestration of p53 in Theileria-transformed cells thus harbors the potential of identifying new interacting proteins regulating p53 localization, which may represent new targets for devising therapeutic strategies against Theileria infection. Moreover, information gained on novel p53-interacting molecules leading to cytoplasmic sequestration of the transcription factor could be relevant for understanding p53 dysfunction due to dysregulated localization in tumor entities where p53 is unmutated. Using the information available from genome sequencing of Theileria parasites (Gardner et al., 2005; Pain et al., 2005) , we have to anticipate the identification of potential parasite-host interacting proteins, also with respect to p53 cytoplasmic sequestration.
Materials and methods
Isolation of bovine peripheral blood mononuclear cells and cell culture Peripheral blood mononuclear cells (PBMCs) from bovine heparinized blood were isolated using Biocoll Separating Solution (Biochrom, Berlin, Germany) and kept in RPMI 1640 complete medium (RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (both from Biochrom), 2 mM L-glutamine and 100 mg/ml penicillin/streptomycin (PAA Laboratories, Linz, Austria)). Concanavalin A (ConA; Biochrom) stimulation at 4 mg/ml was performed with 1 Â 10 7 PBMCs in 25 ml medium for 72 h. Maintenance of the T. annulata-infected bovine cell line TaA288, the T. parva-infected bovine cell line TpM308 and the T. lestoquardi-infected bovine cell line was performed as described (Dobbelaere et al., 1988; Ahmed et al., 1989; Bakheit et al., 2006a) and these cell lines were grown in RPMI 1640 complete medium at 37 1C in an atmosphere of 5% CO 2 .
For buparvaquone treatment, which specifically interacts with the mitochondrial electron transport chain of the parasite (McHardy and Morgan, 1985) and does not influence the vitality of ConA-stimulated bovine PBMCs (Shayan et al., 1999) , we incubated 1 Â 10 7 cells in 25 ml medium and 0.05 mg/ ml buparvaquone up to the desired time points.
Immunofluorescence staining of cells Cells grown on microscope slides or cytospins of isolated schizonts were fixed for 10 min (3% paraformaldehyde in phosphate-buffered saline (PBS), 150 mM NaCl, 10 mM Na 2 HPO 4 Â 2 H 2 O, 1 mM KH 2 PO 4 (pH 7.2)). After permeabilization with 0.25% Triton X-100 in PBS for 10 min and blocking with 10% bovine serum albumin in PBS for 30 min, antibody solutions in 10% bovine serum albumin/PBS were applied to the slides for 30 min. For detection of the schizont membrane, we used an antiserum and a monoclonal antibody against the T. annulata surface protein (Schneider et al., 2004) , monoclonal antibody against the T. parva immunodominant molecule (Toye et al., 1996 , kindly provided by Dirk Geysen, Antwerp, Belgium) and an antiserum against the T. lestoquardi Clone-5 membrane protein (Bakheit et al., 2006b) . The p53-antigen was detected with mouse monoclonal anti-wtp53 antibody (OP33; Oncogene, Bad Soden, Germany). For absorption, we incubated 10 mg/ml antibody for 1 h with recombinantly expressed p53-GST fusion protein (4.4 mg/ml) at 37 1C. Detection was performed using fluorescence-labeled secondary antibodies (anti-rabbit Alexa-488, anti-mouse Alexa-488, anti-rabbit Alexa-546 or anti-mouse Alexa-546) and TOTO-3 or DAPI was used as a nucleic acid dye as indicated (all from Invitrogen, Karlsruhe, Germany). Slides were mounted with DABCO anti-fading solution (2.5% 1.4-diazabicyclo-2.2.2-octane (Sigma, St Louis, MO, USA) in 80% glycerol) and analyzed using a Leica TCS SP confocal laser scanning microscope equipped with an acousto-optical tunable filter and a Â 63 numerical aperture 1.32 plan-apochromat oil-immersion objective (Leica Microsystems, Bensheim, Germany). Images were acquired with the Leica TCSNT software and assembled using Adobe Photoshop 6.0.
LightCycler-based quantification of target cDNA RNA was extracted (Puregene RNA Isolution Kit; Biozym, Hessisch Oldendorf, Germany) and mRNA transcribed into cDNA (cDNA Synthesis Kit; Gibco-BRL, Gaithersburg, MD, USA). Double-stranded cDNA was set to a final concentration of 200 ng/ml. The LightCycler FastStart DNA Master SYBR Green I Kit and the LightCycler Instrument (Roche Diagnostics, Mannheim, Germany) were used for cDNA amplification and quantification of the anti-apoptotic Bcl-2 (Bcl-2 RT-F, 5 0 -GGGGGAACAGGCTACGATAACC; Bcl-2 RT-R, 5 0 -GA CCCCTCCGAACTCAAAGAAG, derived from bovine Bcl-2 sequence (GenBank U92434)) and the proapoptotic Bax (Bax RT-F, 5 0 -GGAGCAGGTGCCCCAGGAGT; Bax RT-R, 5 0 -GGTGAGCGAGGCGGTGAGCA, derived from bovine Bax sequence (GenBank U92569)) and Apaf-1 (Apaf-1 RT-F, 5 0 -ATCACCAGCCGCATACTCT; Apaf-1 RT-R, 5 0 -GTGG GGGCGGACAACTAAG, derived from human Apaf-1 sequence (GenBank AF013263)) transcripts. The final PCR mixture contained FastStart Taq polymerase, 10 mM dNTPs, 2.25 mM MgCl 2 and 0.5 mM of each primer (MWG Biotech AG, Ebersberg, Germany). The cDNA quantification was performed by using an external housekeeping gene standard (GAPDH-F, 5 0 -GTGTATACGGATTTGGTCGCA TC; GAPDH-R, 5 0 -GACAACCTGGTCCTCAGTGTAGC). containing 3 Â 10 5 cells incubated with respective substances (0.05 mM buparvaquone, 13 mM pifithrin-a, 100 mM Bax inhibiting peptide (both from Calbiochem, Merck, Bad Soden, Germany)) and blank, vehicle and inhibitor controls. Measurement of the fluorescence of triplicate samples was performed after 4 h incubation time at an excitation wavelength of 485 nm and an emission wavelength of 525 nm with a fluorescence reader (Tecan GmbH, Crailsheim, Germany). Statistical analysis was performed using two-tailed unpaired Student's t-test where a P-value of o0.05 was considered significant.
SDS-PAGE and immunoblotting
Equal amounts of protein lysate were subjected to SDSpolyacrylamide gel electrophoresis under reducing conditions before transferal onto a nitrocellulose membrane (0.2 mm; Schleicher and Schuell, Dassel, Germany). Membranes were blocked with 3% bovine serum albumin in PBS for 2 h before probing with the primary antibodies (0.5 mg/ml anti-Bax, 1 mg/ml anti-Bcl-2 (both from Oncogene), 1 mg/ml anti-Apaf-1 H-324 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), 1 mg/ml anti-tubulin (DMA1; Sigma, Deisenhofen, Germany), 1 mg/ml rabbit anti-p53 antibody (FL-393; Sigma) and 0.6 mg/ ml mouse anti-GST-antibody (Rockland Inc., Gilbertsville, PA, USA)). Detection was performed using alkaline phosphatase-conjugated goat anti-rabbit, goat anti-mouse or rabbit anti-goat antibody (DakoCytomation, Glostrup, Denmark) followed by incubation with NBT/BCIP (Bio-Rad Laboratories, Munich, Germany).
Isolation of Theileria schizonts Theileria schizonts were isolated by slight modification of a published protocol (Bakheit et al., 2006a) . Briefly, 50 Â 10 6 cells were incubated for 16 h with 20 mM nocodazole (Sigma) at 37 1C. Cells were harvested by centrifugation at 300 g at 4 1C, washed twice with ice-cold PBS (145 mM NaCl, 6 mM Na 2 HPO 4 Â 2 H 2 O, 18 mM NaH 2 PO 4 Â H 2 O) and resuspended in 0.9 ml 1 Â HEPES buffer (10 mM HEPES, 10 mM NaCl, 20 mM KCl (pH 7.4)) containing 1 mM CaCl 2 . Activated aerolysin (Protox Biotech, Victoria, British Columbia, Canada) was added to a final concentration of 15 mg/ml to the cells and incubated for 30 min under rotation at 4 1C. Unbound aerolysin was removed by two washes with ice-cold 1 Â HEPES/CaCl 2 . Cell lysis was performed for 15 min in 2 ml ice-cold 1 Â HEPES containing 5 mM EDTA at 37 1C under gentle agitation. For total cell disruption, we passed cells five times through a 0.6 mm needle. The separation of the schizonts from host cell debris and nuclei was performed by Percoll (Amersham Bioscience, Uppsala, Sweden) gradient ultracentrifugation. Cell lysate (2 ml) was mixed with 7.6 ml 85% (v/v) Percoll in 1 Â HEPES containing 5 mM EDTA and the volume was adjusted to 10 ml giving a final Percoll concentration of 64.6% (v/v). The Percoll cell lysate mixture was transferred into a 13.5 ml centrifuge tube and overlaid with 45% (v/v) Percoll in 1 Â HEPES, 5 mM EDTA. The mixture was centrifuged at 120 000 g for 30 min at 12 1C. After centrifugation, we collected the schizonts accumulated in the interpase and washed them twice with ice-cold PBS at 4000 g for 5 min at 4 1C. In Giemsa-stained cytospin preparations, only a minor degree (approximately 2%) of contamination with host cell nuclei could be observed.
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